Frontotemporal dementia – Basic Information

Go back

Frontotemporal dementia is a group of progressive brain diseases that primarily strike people during their working years, affecting behavior, language, and movement in ways that can profoundly alter who a person is and how they interact with the world around them.

Understanding Frontotemporal Dementia

Frontotemporal dementia, often abbreviated as FTD, is an umbrella term for a group of brain diseases that mainly affect the frontal and temporal lobes of the brain. These are the areas located behind your forehead and behind your ears, which play crucial roles in controlling personality, behavior, and language. In frontotemporal dementia, parts of these lobes shrink, a process known as atrophy, which is the gradual wasting away or shrinking of tissue.[1]

What makes this condition particularly challenging is that it differs significantly from other forms of dementia like Alzheimer’s disease. While most types of dementia primarily affect older adults, frontotemporal dementia tends to strike at a younger age. It most commonly begins between the ages of 40 and 65, though it can occur in older or younger people as well. This means it often affects people who are still working, raising families, and actively engaged in their communities.[1]

The disease is also known by several other names, including frontotemporal lobar degeneration (FTLD) or Pick’s disease, named after Arnold Pick, a physician who first described a patient with distinct language-affecting symptoms in 1892.[5] FTD is the most common form of dementia for people under age 60, with an estimated prevalence of around 60,000 cases in the United States.[3]

Types of Frontotemporal Dementia

Frontotemporal dementia encompasses several distinct clinical syndromes, each affecting different aspects of a person’s functioning. The behavioral variant, known as bvFTD, is the most common type. This form primarily causes changes in personality, behavior, emotions, and judgment. People with this variant may become socially inappropriate, act impulsively, show no emotional response to situations that would normally evoke feelings, or lose their motivation for self-care and hygiene.[2]

Another major category is primary progressive aphasia (PPA), which involves changes in the ability to communicate. This includes speaking, reading, writing, and understanding what others are saying. Within primary progressive aphasia, there are several variants: the nonfluent or agrammatic variant, the semantic variant, and the logopenic variant. Each affects language in slightly different ways.[3]

Some forms of FTD cause problems with movement. Corticobasal degeneration and progressive supranuclear palsy are movement disorders associated with FTD. These conditions can cause muscle stiffness, difficulty with balance and walking, problems with eye movements, and challenges using one side of the body. Additionally, FTD can overlap with other conditions, such as frontotemporal dementia with parkinsonism, which affects movement, language, behavior, and muscle control, or FTD-ALS, which combines symptoms of FTD with the progressive muscle weakness seen in amyotrophic lateral sclerosis (ALS).[2][6]

Epidemiology: Who Gets Frontotemporal Dementia?

Frontotemporal dementia accounts for approximately 10% to 20% of all dementia cases. However, when looking specifically at younger individuals with dementia, FTD becomes much more significant. It is the most common cause of dementia in people under the age of 60.[1][3]

The typical age of onset ranges from 21 to 80 years, but most cases occur between the ages of 45 and 64. About 60% of people with frontotemporal dementia fall within this age range at diagnosis.[4] This is a particularly impactful time in life, as individuals are often at the peak of their careers, managing family responsibilities, and serving as primary earners for their households.

The economic burden of FTD reflects this younger age of onset. The average annual economic impact is approximately $120,000 per year, nearly double the amount associated with Alzheimer’s disease. This substantial cost includes lost income from inability to work, caregiving expenses, and medical care.[3]

Frontotemporal dementia affects people across all populations, though some forms may have slight variations in how common they are across different groups. Unlike some forms of dementia that show clear gender differences, FTD appears to affect men and women relatively equally, though this can vary somewhat by specific subtype.

Causes of Frontotemporal Dementia

Frontotemporal dementia occurs when nerve cells, also called neurons, in the frontal and temporal lobes of the brain die. This happens because abnormal proteins accumulate inside these cells, causing damage. There are two main types of proteins that commonly cause problems in FTD: a protein called tau and another protein called TDP-43. For reasons that scientists don’t yet fully understand, these proteins either build up in excessive amounts or form abnormal shapes that interfere with normal cell function.[2][6]

As these proteins group together within cells, they damage the neurons, eventually causing them to lose function and die. When enough neurons are affected in particular regions, those areas of the brain begin to shrink. This shrinkage, or atrophy, of the frontal and temporal lobes leads to the various symptoms of FTD.[2]

In some cases, genetic factors play a clear role in causing FTD. Studies have identified several genetic variants—changes in the instruction manual that DNA uses to direct specific jobs in the body—that can cause the disease. About 10% to 30% of behavioral variant FTD cases can be attributed to genetic causes. When someone inherits one of these genetic changes, it can lead to the abnormal protein accumulation that causes FTD.[6]

However, in many cases, the exact reason why FTD develops remains unclear. Researchers continue to study why some people develop these abnormal protein accumulations while others don’t, and why the damage targets specific areas of the brain. Understanding these underlying mechanisms is crucial for developing treatments that could slow or prevent the disease.[2]

⚠️ Important
Frontotemporal dementia is frequently misdiagnosed as Alzheimer’s disease, depression, Parkinson’s disease, or a psychiatric condition. On average, it currently takes 3.6 years to get an accurate diagnosis from the time symptoms first appear. If you or a loved one are experiencing personality changes, language difficulties, or unusual behaviors, it’s important to seek evaluation from a specialist familiar with FTD, particularly if these changes occur before age 65.

Risk Factors

Understanding what increases the risk of developing frontotemporal dementia can help in early identification and appropriate monitoring. The most significant risk factor is having a family history of the disease. If FTD runs in your biological family, you may be at higher risk of developing the condition yourself. This is because certain genetic variants can be inherited, passing the risk from one generation to the next.[2]

Another potential risk factor is traumatic brain injury. People who have experienced significant head trauma may face an increased risk of developing FTD later in life. However, the relationship between brain injury and FTD is still being studied, and not everyone who experiences head trauma will develop the disease.[2]

Age is a factor, though not in the way many people might expect. While FTD can occur at any age from young adulthood through old age, the highest risk period is between ages 45 and 64. This differs from Alzheimer’s disease, which primarily affects people over 65.[4]

Recent research suggests that lifestyle factors may also play a role in disease progression, even in people with genetic risk. Studies indicate that a physically and mentally active lifestyle might help build resilience against FTD, potentially delaying symptom onset or slowing progression even in those with genetic predisposition.[17]

Symptoms and How They Affect Daily Life

The symptoms of frontotemporal dementia vary significantly depending on which type a person has and which part of the brain is affected first. This variability is one reason why FTD can be challenging to diagnose. Symptoms typically start mild and gradually worsen over time as more brain cells are affected.[2]

When behavioral changes are the primary symptom, people may experience profound shifts in personality and social behavior. They might act inappropriately in social situations, saying things without any filter or failing to recognize that their behavior is unusual or upsetting to others. A person might lose empathy—the ability to understand or share the feelings of others—making them seem emotionally cold or uncaring when they previously were warm and considerate. Some people develop apathy, which is a lack of motivation or interest in activities, leading to social isolation and neglect of personal hygiene and self-care.[1][2]

Changes in eating behavior are common and can be quite striking. Some people begin overeating or develop strong preferences for sweet foods. Others may engage in pica, which is eating things that aren’t food. These changes reflect damage to the brain regions that control impulses and regulate appetite.[2]

Repetitive behaviors often develop, where a person says or does the same things over and over. They may develop rituals or routines that they must complete in exactly the same way each time. Loss of executive function—the ability to plan, organize, and solve problems—makes it increasingly difficult to manage daily tasks, handle work responsibilities, or make decisions.[2]

When language is primarily affected, people struggle to find the right words, may mix up words, or gradually lose the ability to read and write. Unlike some other forms of dementia, memory problems tend to occur later in FTD rather than being an early symptom. This is an important distinguishing feature from Alzheimer’s disease, where memory loss is typically one of the first signs.[8]

In forms of FTD that affect movement, people may experience muscle stiffness, weakness, slowed movements, or jerking muscle movements. Balance and walking can become impaired, and some people have difficulty with eye movements or swallowing. These physical symptoms can develop alongside or separate from the behavioral and language changes.[2]

Prevention: What Can Be Done?

Currently, there is no proven way to prevent frontotemporal dementia, especially in cases linked to genetic factors. However, emerging research suggests that certain lifestyle choices may help slow disease progression or build resilience, even in people with genetic risk factors.[17]

Physical activity appears to offer protective benefits for brain health. Studies have shown that maintaining a physically active lifestyle may increase resilience to FTD, potentially helping people live longer, more productive lives even when they have genetic predisposition to the disease. This doesn’t mean exercise will prevent FTD, but it may influence how the disease progresses.[17]

Mental and cognitive fitness also seem important. Staying mentally engaged through learning, social activities, puzzles, reading, or other intellectually stimulating pursuits may help build what researchers call “cognitive reserve.” This reserve might help the brain compensate for damage longer, potentially delaying when symptoms become noticeable.[17]

For people with a family history of FTD, genetic counseling and testing can be valuable. While testing won’t prevent the disease, it can help with life planning, clinical trial participation, and preparing for potential future needs. Knowing one’s genetic status also helps ensure that when treatments become available, people can access them as early as possible.[12]

Protecting the brain from injury is another consideration. Since traumatic brain injury has been identified as a potential risk factor, taking steps to prevent head injuries—such as wearing appropriate safety equipment during sports or work, using seatbelts, and preventing falls—makes sense, though the specific preventive benefit for FTD hasn’t been precisely quantified.[2]

How the Disease Changes the Brain: Pathophysiology

To understand frontotemporal dementia, it helps to know what normally happens in the brain regions it affects. The frontal lobes, located behind your forehead, are responsible for executive functions like planning, decision-making, problem-solving, and controlling impulses. They also play a major role in personality and social behavior. The temporal lobes, located roughly behind your ears, are crucial for language comprehension, word finding, and certain types of memory.[4]

In FTD, abnormal proteins accumulate inside neurons in these regions. The two main culprits are tau protein and TDP-43 protein. In healthy brains, these proteins serve normal functions. However, in FTD, they either exist in excessive amounts or take on abnormal forms that the cell cannot properly manage. These misfolded or excessive proteins clump together inside neurons, disrupting normal cell processes.[5][6]

As these protein accumulations grow, they interfere with the neuron’s ability to communicate with other cells, maintain its structure, and carry out its normal functions. Eventually, the affected neurons die. When many neurons in a particular area die, that region of the brain begins to shrink. This shrinkage is visible on brain imaging scans as atrophy of the frontal and temporal lobes.[4]

The specific symptoms a person experiences depend on where in the brain the damage begins and how it spreads. If damage starts primarily in the frontal lobes, behavioral and personality changes tend to appear first. If it begins in the temporal lobes, language problems are usually the initial symptoms. As the disease progresses, it typically spreads to affect more areas of the brain, causing additional symptoms to emerge.[4]

The progression of FTD varies considerably from person to person. The disease causes an inevitable decline in functioning, but the rate can range from 2 years to over 20 years from symptom onset. On average, people live 7 to 13 years after symptoms begin, with pneumonia being the most common cause of death.[3]

⚠️ Important
Over time, people with FTD are predisposed to physical complications including pneumonia, infections, difficulty swallowing, and injuries from falls. As the disease progresses, many people lose all language and communication skills, experience memory loss, and may develop delusions or hallucinations. High levels of care, including 24-hour supervision, may become necessary. Planning ahead for financial, legal, and care arrangements is essential once a diagnosis is made.

Ongoing Clinical Trials on Frontotemporal dementia

  • Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia France Italy The Netherlands Portugal +1
  • Study on AVB-101 for Patients with Frontotemporal Dementia with Progranulin Mutations

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy The Netherlands Poland Spain Sweden
  • Study on the Safety and Effects of LY3884963 for Patients with Fronto-Temporal Dementia with Progranulin Mutations

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium France
  • Study on the Effects of Latozinemab for Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Italy The Netherlands +3

References

https://www.mayoclinic.org/diseases-conditions/frontotemporal-dementia/symptoms-causes/syc-20354737

https://my.clevelandclinic.org/health/diseases/21075-frontotemporal-dementia

https://www.theaftd.org/what-is-ftd/disease-overview/

https://www.nia.nih.gov/health/frontotemporal-disorders/what-are-frontotemporal-disorders-causes-symptoms-and-treatment

https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/frontotemporal-dementia

https://www.alzheimers.gov/alzheimers-dementias/frontotemporal-dementia

https://www.alzheimers.org.uk/about-dementia/types-dementia/frontotemporal-dementia

https://www.nhs.uk/conditions/frontotemporal-dementia/

https://www.mayoclinic.org/diseases-conditions/frontotemporal-dementia/diagnosis-treatment/drc-20354741

https://www.nhs.uk/conditions/frontotemporal-dementia/treatment/

https://pmc.ncbi.nlm.nih.gov/articles/PMC4920050/

https://www.theaftd.org/for-health-professionals/treating-ftd/

https://www.alzheimers.org.uk/about-dementia/types-dementia/treatment-support-frontotemporal-dementia

https://my.clevelandclinic.org/health/diseases/21075-frontotemporal-dementia

https://www.nia.nih.gov/health/frontotemporal-disorders/caring-person-frontotemporal-disorder

https://www.theaftd.org/living-with-ftd/managing-ftd/

https://www.ucsf.edu/news/2020/01/416391/lifestyle-choices-could-slow-familial-frontotemporal-dementia

https://www.alzheimers.gov/life-with-dementia/tips-caregivers

https://www.nhs.uk/conditions/frontotemporal-dementia/treatment/

https://my.clevelandclinic.org/health/diseases/21075-frontotemporal-dementia

FAQ

How is frontotemporal dementia different from Alzheimer’s disease?

FTD differs from Alzheimer’s disease in several key ways. It typically strikes at a younger age, most commonly between 45 and 64, while Alzheimer’s usually affects people over 65. The initial symptoms are also different—FTD usually begins with personality changes, behavioral problems, or language difficulties, while Alzheimer’s typically starts with memory loss. Additionally, FTD is caused by different protein abnormalities (tau and TDP-43) compared to Alzheimer’s (amyloid and tau), and it affects different brain regions (frontal and temporal lobes rather than the memory centers).

Is frontotemporal dementia hereditary?

About 10% to 30% of behavioral variant FTD cases have a genetic cause. If FTD runs in your biological family history, you may be at higher risk. However, many cases occur without any family history, and the exact cause remains unclear in these situations. Genetic counseling and testing can help people with a family history understand their personal risk and make informed decisions about planning and participation in clinical trials.

Why does it take so long to diagnose FTD?

FTD is frequently misdiagnosed as Alzheimer’s disease, depression, Parkinson’s disease, or a psychiatric condition because many healthcare providers are unfamiliar with it. The unusual behavioral symptoms can look like mental health problems rather than dementia, especially in younger people. Currently, it takes an average of 3.6 years to get an accurate diagnosis. Seeking evaluation at a specialized memory center or from doctors familiar with younger-onset dementia can help speed accurate diagnosis.

Are there any treatments for frontotemporal dementia?

Currently, there is no cure for FTD and no FDA-approved treatments to slow or stop its progression. However, treatments can help manage symptoms. Medications called SSRIs (selective serotonin reuptake inhibitors) may help with behavioral symptoms like impulsivity, aggression, and repetitive behaviors. Physical, occupational, and speech therapy can help manage movement and communication difficulties. Research is ongoing, and multiple clinical trials are testing potential disease-modifying treatments.

Can lifestyle changes help slow FTD progression?

Recent research suggests that maintaining a physically and mentally active lifestyle may provide some resilience against FTD, even in people with genetic predisposition. Studies indicate that exercise and cognitive engagement might help people live longer and maintain function better, though these activities cannot prevent the disease entirely. Staying active, socially engaged, and mentally stimulated may be beneficial, though more research is needed to fully understand these effects.

🎯 Key takeaways

  • FTD is the most common form of dementia in people under 60, typically striking between ages 45 and 64 when people are still working and raising families.
  • Unlike Alzheimer’s disease, FTD usually starts with personality changes, behavioral problems, or language difficulties rather than memory loss.
  • The disease is often misdiagnosed as depression or a psychiatric condition, taking an average of 3.6 years to receive accurate diagnosis.
  • About 10-30% of behavioral variant FTD cases have an identifiable genetic cause, making family history an important risk factor.
  • The economic burden of FTD is approximately $120,000 per year—nearly double that of Alzheimer’s—due to lost work income and caregiving costs.
  • While there’s no cure, lifestyle factors like physical and mental activity may help build resilience and slow progression even in those with genetic risk.
  • The disease progression varies widely from 2 to over 20 years, with average survival of 7 to 13 years after symptom onset.
  • Numerous clinical trials are underway testing potential treatments, making genetic testing and participation in research increasingly important for advancing care.